Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

TOI Financial Statements and Analysis

NASDAQ : TOI

The Oncology Institute, Inc.

$1.14
0.03+2.70%
At Close 4:00 PM
63.41
BESG ScoreESG Rating

TOI FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

TOI Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue99.901M98.578M94.666M85.788M82.035M
cost of revenue85.535M85.552M84.186M72.986M66.057M
gross profit14.366M13.026M10.48M12.802M15.978M
gross profit ratio0.1440.1320.1110.1490.195
research and development expenses00000
general and administrative expenses00000
selling and marketing expenses00000
selling general and administrative expenses26.646M27.872M28.452M28.088M28.205M
other expenses1.573M1.518M68.00K-350.00K-140.00K
operating expenses28.219M29.39M28.452M28.088M29.903M
cost and expenses113.754M114.942M112.638M101.074M95.96M
interest income000-3.181M940.00K
interest expense2.225M2.118M1.985M-1.24M2.695M
depreciation and amortization1.573M1.518M1.489M1.577M1.698M
ebitda-12.315M-14.846M-16.415M-13.709M-11.427M
ebitda ratio-0.123-0.151-0.174-0.16-0.139
operating income-13.853M-16.364M-17.972M-15.286M-13.925M
operating income ratio-0.139-0.166-0.19-0.178-0.17
total other income expenses net-2.26M885.00K-1.917M-3.555M-1.604M
income before tax-16.113M-15.479M-19.889M-18.841M-17.284M
income before tax ratio-0.161-0.157-0.21-0.22-0.211
income tax expense00-3.617M-87.00K135.00K
net income-16.113M-15.479M-16.272M-15.314M-17.419M
net income ratio-0.161-0.157-0.172-0.179-0.212
eps-0.18-0.17-0.22-0.21-0.24
eps diluted-0.18-0.17-0.22-0.21-0.24
weighted average shs out75.525M74.748M74.234M73.469M73.469M
weighted average shs out dil75.525M74.748M74.234M73.469M73.469M
Graph

TOI Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents47.402M36.424M36.055M33.488M27.535M
short term investments09.939M29.777M49.367M59.877M
cash and short term investments47.402M46.363M65.832M82.855M87.412M
net receivables54.86M54.367M59.128M42.911M48.906M
inventory10.106M11.322M11.554M13.678M12.174M
other current assets4.057M4.157M4.678M4.049M4.19M
total current assets116.425M116.209M141.192M143.493M152.682M
property plant equipment net39.357M39.224M38.411M40.052M39.32M
goodwill7.23M7.23M7.23M7.23M7.23M
intangible assets15.583M16.357M17.131M17.904M18.561M
goodwill and intangible assets22.813M23.587M24.361M25.134M25.791M
long term investments00-32.00K0-158.00K
tax assets0032.00K10.178M158.00K
other non current assets588.00K582.00K568.00K561.00K560.00K
total non current assets62.758M63.393M63.34M75.925M65.671M
other assets00000
total assets179.183M179.602M204.532M219.418M218.353M
account payables24.572M15.75M21.015M14.429M13.333M
short term debt6.749M13.042M6.39M6.403M6.079M
tax payables0000255.00K
deferred revenue0861.00K964.00K545.00K545.00K
other current liabilities15.436M5.449M17.399M13.411M12.433M
total current liabilities46.757M35.102M45.768M34.788M32.39M
long term debt116.201M114.485M113.445M86.826M111.268M
deferred revenue non current0025.06M26.586M2.229M
deferred tax liabilities non current32.00K32.00K32.00K10.21M158.00K
other non current liabilities711.00K777.00K3.991M3.983M459.00K
total non current liabilities116.944M115.294M117.468M127.605M114.114M
other liabilities001.0000
capital lease obligations31.413M31.056M25.06M26.586M32.093M
total liabilities163.701M150.396M163.236M162.393M146.504M
preferred stock00000
common stock08.00K8.00K8.00K8.00K
retained earnings-197.631M-181.518M-166.039M-146.15M-127.396M
accumulated other comprehensive income loss00000
other total stockholders equity213.113M210.716M207.327M203.167M199.237M
total stockholders equity15.482M29.206M41.296M57.025M71.849M
total equity15.482M29.206M41.296M57.025M71.849M
total liabilities and stockholders equity179.183M179.602M204.532M219.418M218.353M
minority interest00000
total investments09.939M29.777M49.367M59.877M
total debt122.95M121.006M119.835M119.815M117.347M
net debt75.548M84.582M83.78M86.327M89.812M
Graph

TOI Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateJun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax99.00K0-126.00K80.00K-4.00K
stock based compensation3.387M4.087M4.079M4.659M4.107M
change in working capital-3.406M-2.732M6.446M-1.111M1.801M
accounts receivables4.761M-16.217M4.006M-2.081M-435.00K
inventory232.00K2.124M-1.472M-6.00K-1.914M
accounts payables-5.459M6.357M1.096M210.00K1.177M
other working capital-2.94M5.004M2.816M766.00K2.973M
other non cash items2.409M12.346M-555.00K3.783M1.004M
net cash provided by operating activities-15.66M-15.883M-3.893M-8.31M-8.66M
investments in property plant and equipment-1.826M-610.00K-861.00K-930.00K-937.00K
acquisitions net00-156.00K-8.639M-4.30M
purchases of investments0088.00K64.00K12.00K
sales maturities of investments20.002M19.998M12.556M8.575M30.128M
other investing activites20.002M19.998M08.639M0
net cash used for investing activites18.176M19.388M11.627M7.709M24.903M
debt repayment-9.00K-9.00K-10.00K-10.00K-63.00K
common stock issued2.00K73.00K113.00K13.00K0
common stock repurchased000-125.00K-894.00K
dividends paid000-13.00K0
other financing activites-2.14M-1.002M-1.884M-621.00K-1.644M
net cash used provided by financing activities-2.147M-938.00K-1.781M-756.00K-2.601M
effect of forex changes on cash0011.00K-9.572M-25.004M
net change in cash369.00K2.567M5.953M-1.357M13.642M
cash at end of period36.424M36.055M33.488M27.535M28.892M
cash at beginning of period36.055M33.488M27.535M28.892M15.25M
operating cashflow-15.66M-15.883M-3.893M-8.31M-8.66M
capital expenditure-1.826M-610.00K-861.00K-930.00K-937.00K
free cash flow-17.486M-16.493M-4.754M-9.24M-9.597M
Graph

Frequently Asked Questions

How did The Oncology Institute, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, TOI generated $99.90M in revenue last quarter, while its costs came in at $85.54M.
Last quarter, how much Gross Profit did The Oncology Institute, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. The Oncology Institute, Inc. reported a $14.37M Gross Profit for the quarter ended Jun 30, 2024.
Have TOI's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. TOI incurred $28.22M worth of Operating Expenses, while it generated -$13.85M worth of Operating Income.
How much Net Income has TOI posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from The Oncology Institute, Inc., the company generated -$16.11M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did The Oncology Institute, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to The Oncology Institute, Inc. as of the end of the last quarter was $47.40M.
What are TOI's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, TOI had Total Net Receivables of $54.86M.
In terms of Total Assets and Current Assets, where did The Oncology Institute, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of TOI were $116.43M, while the Total Assets stand at $179.18M.
As of the last quarter, how much Total Debt did The Oncology Institute, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of TOI's debt was $122.95M at the end of the last quarter.
What were TOI's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, TOI reported total liabilities of $163.70M.
How much did TOI's Working Capital change over the last quarter?
Working Capital Change for TOI was -$3.41M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
TOI generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. TOI generated -$15.66M of Cash from Operating Activities during its recently reported quarter.
What was TOI's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. TOI reported a $369.00K Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph